Companies / Array Biopharma Inc
Array Biopharma Inc
ARRYCIK 1100412
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 1, 2015 | Squarer Ron CEO | Exercise Option exercise | Common Stock | $619.9K | +78K | 77,881 | low |
| Mar 3, 2015 | Lefkoff Kyle Director | Sell Open-market sale | Common Stock | $560.1K | -70K -95.13% | 3,585 | medium |
| Mar 2, 2015 | Squarer Ron CEO | Sell Open-market sale | Common Stock | $330.0K | -40K -75.58% | 12,927 | medium |
| Mar 1, 2015 | Robbins Andrews R Executive | Exercise Option exercise | Common Stock | $255.3K | +32K | 32,069 | low |
| Mar 1, 2015 | Squarer Ron CEO | Other Withheld for taxes | Common Stock | $198.6K | -25K -32.04% | 52,927 | low |
| May 8, 2015 | Baum Charles M Director | Sell Open-market sale | Common Stock | $184.5K | -25K -100.00% | 0 | medium |
| Mar 1, 2015 | Moore John R Executive | Exercise Option exercise | Common Stock | $182.3K | +23K | 22,906 | low |
| Mar 2, 2015 | Robbins Andrews R Executive | Sell Open-market sale | Common Stock | $178.0K | -22K -100.00% | 0 | medium |